ClinicalTrials.Veeva

Menu

A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection

Mayo Clinic logo

Mayo Clinic

Status

Terminated

Conditions

Covid19

Study type

Observational

Funder types

Other

Identifiers

NCT04725097
20-011415

Details and patient eligibility

About

The purpose of this study is to assess the ability of an artificial intelligence smartphone-enabled point of care ECG to detect COVID-19.

Enrollment

2,821 patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult males and females age 18 or greater.
  • Undergoing COVID-19 testing by PCR.
  • Willing and able to provide informed consent.
  • Pregnant females (minimal risk study, no risk from ECG).

Exclusion criteria

  • Unwilling or unable to provide informed consent.

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems